US 12163169
Inducible chimeric cytokine receptors
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12163169 (Inducible chimeric cytokine receptors) held by Allogene Therapeutics, Inc. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K35/17, A61K38/00